Close Menu

NEW YORK (360DX) – Quest Diagnostics announced today a definitive agreement to acquire Cleveland HeartLab from equity investors including Cleveland Clinic.

Quest plans to create its first national center of excellence in cardiometabolic disorders at the lab. It and Cleveland Clinic will collaborate strategically on the center's development, Quest said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Aug
19
Sponsored by
UgenTec

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.